Growth Metrics

Masimo (MASI) Other financing activities (2009 - 2026)

Masimo's quarterly Other financing activities came in at $6.3 million in Q1 2026, up 184.0% year-on-year from $2.2 million in Q1 2025, and up 800.0% quarter-over-quarter from -$900000.0 in Q3 2025.

Masimo has reported Other financing activities for 13 years, with the latest figure at $6.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Other financing activities rose 184.0% year-over-year to $6.3 million; the trailing twelve-month figure through Apr 2026 stood at $4.5 million (up 1225.0% YoY), and the FY2026 full-year result was $3.7 million, changed N/A from the prior year.
  • Other financing activities for Q1 2026 stood at $6.3 million, up from -$900000.0 in the prior quarter.
  • The five-year high for Other financing activities was $8.3 million in Q3 2024, with the low at -$7.5 million in Q4 2024.
  • Average Other financing activities over 4 years is $455555.6, with a median of -$400000.0 recorded in 2024.
  • Year-over-year, Other financing activities slumped 125.0% in 2025 and surged 184.0% in 2026.
  • Tracing MASI's Other financing activities over 4 years: stood at $400000.0 in 2022, then tumbled by 1975.0% to -$7.5 million in 2024, then surged by 88.0% to -$900000.0 in 2025, then jumped by 800.0% to $6.3 million in 2026.
  • The last three Other financing activities figures came in at $6.3 million (Q1 2026), -$900000.0 (Q3 2025), and -$900000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Masimo 9.32 Bn 9.20 Bn 250.80 Mn

Historic Data

Download Data 🔒
DateValue
Jan 3, 2026 6.30 Mn
Jan 3, 2026 6.30 Mn
Sep 27, 2025 -900,000.00
Sep 27, 2025 -900,000.00
Jun 28, 2025 -900,000.00
Jun 28, 2025 -900,000.00
Mar 29, 2025 -800,000.00
Mar 29, 2025 -800,000.00
Dec 28, 2024 -7.50 Mn
Dec 28, 2024 -7.50 Mn
Sep 28, 2024 8.30 Mn
Sep 28, 2024 8.30 Mn
Jun 29, 2024 -400,000.00
Jun 29, 2024 -400,000.00
Mar 30, 2024 -400,000.00
Mar 30, 2024 -400,000.00
Oct 1, 2022 400,000.00
Oct 1, 2022 400,000.00
Dec 30, 2017 -71,000.00
Dec 30, 2017 -71,000.00
Dec 31, 2016 -1.32 Mn
Dec 31, 2016 -1.32 Mn
Jul 2, 2016 618,000.00
Jul 2, 2016 618,000.00
Jan 2, 2016 74,000.00
Jan 2, 2016 74,000.00
Apr 4, 2015 3,000.00
Apr 4, 2015 3,000.00
Sep 27, 2014 -36,000.00
Sep 27, 2014 -36,000.00
Jun 28, 2014 4,000.00
Jun 28, 2014 4,000.00
Mar 29, 2014 -42,000.00
Mar 29, 2014 -42,000.00
Dec 28, 2013 759,000.00
Dec 28, 2013 759,000.00
Sep 28, 2013 -255,000.00
Sep 28, 2013 -255,000.00
Jun 29, 2013 -340,000.00
Jun 29, 2013 -340,000.00
Mar 30, 2013 -164,000.00
Mar 30, 2013 -164,000.00
Dec 29, 2012 340,000.00
Dec 29, 2012 340,000.00
Sep 29, 2012 -55,000.00
Sep 29, 2012 -55,000.00
Jun 30, 2012 -118,000.00
Jun 30, 2012 -118,000.00
Mar 31, 2012 -167,000.00
Mar 31, 2012 -167,000.00
Dec 31, 2011 9,000.00
Dec 31, 2011 9,000.00
Oct 1, 2011 -31,000.00
Oct 1, 2011 -31,000.00
Jul 2, 2011 287,000.00
Jul 2, 2011 287,000.00
Apr 2, 2011 -198,000.00
Apr 2, 2011 -198,000.00
Jan 1, 2011 522,000.00
Jan 1, 2011 522,000.00
Apr 3, 2010 1.38 Mn
Apr 3, 2010 1.38 Mn
Oct 3, 2009 33,000.00
Oct 3, 2009 33,000.00